Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med. 1997;127(10):875-881.

Publication Type:

Journal Article

Authors:

P. Marcellin; Boyer, N.; Gervais, A.; Martinot, M.; Pouteau, M.; Castelnau, C.; Kilani, A.; Areias, J.; Auperin, A.; Benhamou, J.P.; Degott, C.; Erlinger, S.

Source:

Ann Intern Med, Volume 127, Issue 10, p.875-881 (1997)

Keywords:

Cited On:

When and in Whom to Initiate HCV Therapy

Export Citation:

RIS Format

Top